Center for Scientific Review; Notice of Closed Meetings, 27884-27885 [2014-11133]
Download as PDF
<![CDATA[
27884
Federal Register / Vol. 79, No. 94 / Thursday, May 15, 2014 / Notices
Section, June 05, 2014, 08:00 a.m. to
June 06, 2014, 06:00 p.m., Residence Inn
Bethesda, 7335 Wisconsin Avenue,
Bethesda, MD, 20814 which was
published in the Federal Register on
May 07, 2014, 79 FR 26261.
The meeting will be held on June 5,
2014. The meeting location and time
remain the same. The meeting is closed
to the public.
Dated: May 9, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–11144 Filed 5–14–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
TKELLEY on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neural Trauma, Stroke and
Epilepsy.
Date: June 6, 2014.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Alexei Kondratyev,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5200,
MSC 7846, Bethesda, MD 20892, 301–435–
1785, kondratyevad@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Cancer,
Cardiovascular, and Sleep Epidemiology
Panel A.
Date: June 9, 2014.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
VerDate Mar<15>2010
18:18 May 14, 2014
Jkt 232001
Contact Person: Denise Wiesch, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3138,
MSC 7770, Bethesda, MD 20892, (301) 437–
3478, wieschd@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group;
Neuroendocrinology, Neuroimmunology,
Rhythms and Sleep Study Section.
Date: June 9–10, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Admiral Fell Inn, 888 South
Broadway, Baltimore, MD 21231.
Contact Person: Michael Selmanoff, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5164,
MSC 7844, Bethesda, MD 20892, 301–435–
1119, mselmanoff@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Clinical Oncology Study Section.
Date: June 9, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sir Francis Drake Hotel, 450 Powell
Street at Sutter, San Francisco, CA 94102.
Contact Person: Malaya Chatterjee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, 301–806–
2515, chatterm@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Somatosensory and
Chemosensory Systems Study Section.
Date: June 10–11, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites DC Convention
Center, 900 10th Street NW., Washington, DC
20001.
Contact Person: M Catherine Bennett,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7846, Bethesda, MD 20892, 301–435–
1766, bennettc3@csr.nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Modeling and Analysis of Biological
Systems Study Section.
Date: June 10, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Craig Giroux, Ph.D.,
Scientific Review Officer, BST IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5150,
Bethesda, MD 20892, 301–435–2204,
girouxcn@csr.nih.gov.
Name of Committee: Interdisciplinary
Molecular Sciences and Training Integrated
Review Group; Enabling Bioanalytical and
Imaging Technologies Study Section.
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Date: June 10–11, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Washington DC,
Dupont Circle, 1143 New Hampshire Avenue
NW., Washington, DC 20037.
Contact Person: Dennis Hlasta, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6185,
MSC 7892, Bethesda, MD 20892, 301–435–
1047, dennis.hlasta@nih.gov.
Name of Committee: Biology of
Development and Aging Integrated Review
Group; International and Cooperative
Projects—1 Study Section.
Date: June 10, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Manhattan Beach Marriott Hotel and
Golf Club, 1400 Parkview Avenue,
Manhattan Beach, CA 90266.
Contact Person: Hilary D. Sigmon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222,
MSC 7852, Bethesda, MD 20892, (301) 594–
6377, sigmonh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Investigations on Primary Immunodeficiency
Diseases.
Date: June 10, 2014.
Time: 11:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Scott Jakes, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4198,
MSC 7812, Bethesda, MD 20892, 301–495–
1506, jakesse@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–14–
008: Secondary Analysis to Explore NIMH
Research Domain Criteria.
Date: June 10, 2014.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Julius Cinque, MS,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186,
MSC 7846, Bethesda, MD 20892, (301) 435–
1252, cinquej@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Liver and Gastrointestinal
Physiology and Pathophysiology.
Date: June 10, 2014.
Time: 1:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
E:\FR\FM\15MYN1.SGM
15MYN1
Federal Register / Vol. 79, No. 94 / Thursday, May 15, 2014 / Notices
Contact Person: Martha Garcia, Ph.D.,
Scientific Reviewer Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2186,
MSC 7818, Bethesda, MD 20892, 301–435–
1243, garciamc@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 8, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–11133 Filed 5–14–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Start-Up
Exclusive Evaluation Option License
Agreement: Nitric Oxide (NO)
Releasing Materials for Use in Medical
Devices Related to Microbial
Management and Wound Care
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
This is notice, in accordance
with 35 U.S.C. 209 and 37 CFR part 404,
that the National Institutes of Health,
Department of Health and Human
Services, is contemplating the grant of a
Start-Up Exclusive Evaluation Option
License Agreement to iFyber LLC, a
company having a place of business in
Ithaca, New York to practice the
inventions embodied in the following
patent applications and patents:
TKELLEY on DSK3SPTVN1PROD with NOTICES
SUMMARY:
1. U.S. Patent 7,968,664, issued June 28,
2011, titled ‘‘Nitric Oxide Releasing
Diazeniumdiolated Acrylonitrile-Based
Polymers, And Compositions, Medical
Devices, And Uses Thereof’’ [HHS Ref.
No. E–188–2004/0–US–06];
2. U.S. Patent 8,093,343, issued January 10,
2012, titled ‘‘Nitric Oxide-Releasing
Diazeniumdiolated Compounds’’ [HHS
Ref. No. E–188–2004/0–US–08];
3. European Patent Application 05802080.1,
filed September 27, 2005, titled ‘‘Nitric
Oxide Releasing Diazeniumdiolated
Acrylonitrile-Based Polymers, And
Compositions, Medical Devices, And
Uses Thereof’’ [HHS Ref. No. E–188–
2004/0–EP–05];
4. Canadian Patent 2581939, issued January
8, 2013, titled ‘‘Nitric Oxide Releasing
Diazeniumdiolated Acrylonitrile-Based
Polymers, And Compositions, Medical
Devices, And Uses Thereof’’ [HHS Ref.
No. E–188–2004/0–CA–04];
5. Australian Patent Application 2005289414,
filed September 27, 2005, titled ‘‘Nitric
VerDate Mar<15>2010
18:18 May 14, 2014
Jkt 232001
Oxide Releasing Diazeniumdiolated
Acrylonitrile-Based Polymers, And
Compositions, Medical Devices, And
Uses Thereof’’ [HHS Ref. No. E–188–
2004/0–AU–03]; and
6. Australian Patent 2011200972, issued July
5, 2012, titled ‘‘Nitric Oxide-Releasing
Compounds and Uses Thereof’’ [HHS
Ref. No. E–188–2004/0–AU–07]
The patent rights in these inventions
have been assigned to the Government
of the United States of America. The
territory of the prospective Start-up
Exclusive Evaluation Option License
Agreement may be worldwide, and the
field of use may be limited to: ‘‘Nitric
oxide (NO) releasing materials for use in
medical/surgical tubing and attachment
devices related to tubing; and wound
healing devices, including wound
dressings/bandages.’’
Upon the expiration or termination of
the Start-up Exclusive Evaluation
Option License Agreement, iFyber will
have the exclusive right to execute a
Start-up Exclusive Patent License
Agreement which will supersede and
replace the Start-up Exclusive
Evaluation Option License Agreement,
with no greater field of use and territory
than granted in the Start-up Exclusive
Evaluation Option License Agreement.
DATES: Only written comments and/or
applications for a license which are
received by the NIH Office of
Technology Transfer on or before May
30, 2014 will be considered.
ADDRESSES: Requests for copies of the
patents, patent applications, inquiries,
comments, and other materials relating
to the contemplated Start-Up Exclusive
Evaluation Option License Agreement
should be directed to: Betty B. Tong,
Ph.D., Senior Licensing and Patenting
Manager, Office of Technology Transfer,
National Institutes of Health, 6011
Executive Boulevard, Suite 325,
Rockville, MD 20852–3804; Telephone:
(301) 594–6565; Facsimile: (301) 402–
0220; Email: tongb@mail.nih.gov. A
signed confidentiality nondisclosure
agreement will be required to receive
copies of any patent applications that
have not been published or issued by
the United States Patent and Trademark
Office or the World Intellectual Property
Organization.
SUPPLEMENTARY INFORMATION: The
subject invention describes a family of
polymers based on poly(acrylonitrile)
that are capable of storing Nitric oxide
(NO) bound in a stable chemical
functionality, called a diazeniumdiolate
group, and releasing NO under aqueous
conditions. The incorporation of these
NO-releasing diazeniumdiolated
acrylonitrile-based compositions into
suitable, biocompatible dressings could
be used to treat wounds to fight
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
27885
infection, modulate inflammation, and
promote angiogenesis and collagen
synthesis in order to accelerate wound
closure and/or otherwise improve
functional outcomes. These
polyacrylonitrile-based products could
be useful in conjunction with medical
devices where the many therapeutic
actions of NO would be beneficial.
The prospective Start-up Exclusive
Evaluation Option License Agreement
and a subsequent Start-up Exclusive
Patent License Agreement may be
granted unless the NIH receives written
evidence and argument, within fifteen
(15) days from the date of this published
notice, that establishes that the grant of
the contemplated Start-up Exclusive
Evaluation Option License Agreement
would not be consistent with the
requirements of 35 U.S.C. 209 and 37
CFR part 404.
Complete applications for a license in
the prospective field of use that are filed
in response to this notice will be treated
as objections to the grant of the
contemplated Start-Up Exclusive
Evaluation Option License Agreement.
Comments and objections submitted in
response to this notice will not be made
available for public inspection and, to
the extent permitted by law, will not be
released under the Freedom of
Information Act, 5 U.S.C. 552.
Dated: May 12, 2014.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2014–11145 Filed 5–14–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[USCG–2013–1073]
Collection of Information Under
Review by Office of Management and
Budget
Coast Guard, DHS.
Thirty-day notice requesting
comments.
AGENCY:
ACTION:
In compliance with the
Paperwork Reduction Act of 1995 the
U.S. Coast Guard is forwarding
Information Collection Requests (ICRs),
abstracted below, to the Office of
Management and Budget (OMB), Office
of Information and Regulatory Affairs
(OIRA), requesting approval of a
Revision to the following collections of
information: 1625–0017, Various
International Agreement Safety
SUMMARY:
E:\FR\FM\15MYN1.SGM
15MYN1
]]>Agencies
[Federal Register Volume 79, Number 94 (Thursday, May 15, 2014)]
[Notices]
[Pages 27884-27885]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-11133]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Neural Trauma, Stroke and Epilepsy.
Date: June 6, 2014.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Alexei Kondratyev, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301-435-
1785, kondratyevad@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Cancer, Cardiovascular, and Sleep Epidemiology Panel A.
Date: June 9, 2014.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Denise Wiesch, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3138, MSC 7770, Bethesda, MD 20892, (301) 437-
3478, wieschd@csr.nih.gov.
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group; Neuroendocrinology,
Neuroimmunology, Rhythms and Sleep Study Section.
Date: June 9-10, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Admiral Fell Inn, 888 South Broadway, Baltimore, MD
21231.
Contact Person: Michael Selmanoff, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5164, MSC 7844, Bethesda, MD
20892, 301-435-1119, mselmanoff@csr.nih.gov.
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Clinical Oncology Study Section.
Date: June 9, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Sir Francis Drake Hotel, 450 Powell Street at Sutter, San
Francisco, CA 94102.
Contact Person: Malaya Chatterjee, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD
20892, 301-806-2515, chatterm@csr.nih.gov.
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group; Somatosensory and Chemosensory
Systems Study Section.
Date: June 10-11, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites DC Convention Center, 900 10th Street NW.,
Washington, DC 20001.
Contact Person: M Catherine Bennett, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182, MSC 7846, Bethesda, MD
20892, 301-435-1766, bennettc3@csr.nih.gov.
Name of Committee: Bioengineering Sciences & Technologies
Integrated Review Group; Modeling and Analysis of Biological Systems
Study Section.
Date: June 10, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Craig Giroux, Ph.D., Scientific Review Officer,
BST IRG, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5150, Bethesda, MD 20892, 301-
435-2204, girouxcn@csr.nih.gov.
Name of Committee: Interdisciplinary Molecular Sciences and
Training Integrated Review Group; Enabling Bioanalytical and Imaging
Technologies Study Section.
Date: June 10-11, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance Washington DC, Dupont Circle, 1143 New
Hampshire Avenue NW., Washington, DC 20037.
Contact Person: Dennis Hlasta, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6185, MSC 7892, Bethesda, MD 20892, 301-435-
1047, dennis.hlasta@nih.gov.
Name of Committee: Biology of Development and Aging Integrated
Review Group; International and Cooperative Projects--1 Study
Section.
Date: June 10, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Manhattan Beach Marriott Hotel and Golf Club, 1400
Parkview Avenue, Manhattan Beach, CA 90266.
Contact Person: Hilary D. Sigmon, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222, MSC 7852, Bethesda, MD
20892, (301) 594-6377, sigmonh@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA Panel: Investigations on Primary Immunodeficiency
Diseases.
Date: June 10, 2014.
Time: 11:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Scott Jakes, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4198, MSC 7812, Bethesda, MD 20892, 301-495-
1506, jakesse@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-14-008: Secondary Analysis to Explore NIMH Research
Domain Criteria.
Date: June 10, 2014.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Julius Cinque, MS, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5186, MSC 7846, Bethesda, MD 20892, (301) 435-
1252, cinquej@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts: Liver and Gastrointestinal Physiology and
Pathophysiology.
Date: June 10, 2014.
Time: 1:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
[[Page 27885]]
Contact Person: Martha Garcia, Ph.D., Scientific Reviewer
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2186, MSC 7818, Bethesda, MD
20892, 301-435-1243, garciamc@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: May 8, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-11133 Filed 5-14-14; 8:45 am]
BILLING CODE 4140-01-P
